Gina Chapman, CARGO Therapeutics CEO
Cell therapy biotech from Stanford CAR-T leader Crystal Mackall nabs $200M for PhII
A biotech born out of the work of Stanford CAR-T leader Crystal Mackall is publicly unveiling its $200 million Series A Wednesday, after already going …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.